These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8502812)

  • 1. The world overview at 10 years: what did we learn about the results of chemotherapy?
    Baum M
    Recent Results Cancer Res; 1993; 127():163-6. PubMed ID: 8502812
    [No Abstract]   [Full Text] [Related]  

  • 2. What did we learn from the results of the international overview about the effects of endocrine therapy?
    Bonadonna G
    Recent Results Cancer Res; 1993; 127():159-61. PubMed ID: 8502811
    [No Abstract]   [Full Text] [Related]  

  • 3. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 4. Adjuvant systemic therapy: overview.
    Henderson IC
    Recent Results Cancer Res; 1993; 127():197-200. PubMed ID: 8502816
    [No Abstract]   [Full Text] [Related]  

  • 5. Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials.
    Tormey DC; Gray R; Falkson HC; Gilchrist K; Abeloff MD; Falkson G
    Recent Results Cancer Res; 1993; 127():185-96. PubMed ID: 8502815
    [No Abstract]   [Full Text] [Related]  

  • 6. Adjuvant treatment for breast cancer: the overview.
    Gelber RD; Coates AS; Goldhirsch A
    BMJ; 1992 Apr; 304(6831):859-60. PubMed ID: 1392742
    [No Abstract]   [Full Text] [Related]  

  • 7. Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.
    Taghian AG; Jeong JH; Mamounas EP; Parda DS; Deutsch M; Costantino JP; Wolmark N
    J Clin Oncol; 2006 Aug; 24(24):3927-32. PubMed ID: 16921044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 9. 21-Gene Recurrence Score for prognosis and prediction of taxane benefit after adjuvant chemotherapy plus endocrine therapy: results from NSABP B-28/NRG Oncology.
    Mamounas EP; Tang G; Paik S; Baehner FL; Liu Q; Jeong JH; Kim SR; Butler SM; Jamshidian F; Cherbavaz DB; Sing AP; Shak S; Julian TB; Lembersky BC; Lawrence Wickerham D; Costantino JP; Wolmark N
    Breast Cancer Res Treat; 2018 Feb; 168(1):69-77. PubMed ID: 29128898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of adjuvant systemic therapy in organ preserving treatment of pT1-2N0M0 breast cancer].
    Semiglazov VF; Kanaev SV; Bugrova IL; Vlasov AN
    Vopr Onkol; 1999; 45(5):516-9. PubMed ID: 10629708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Recent advance in adjuvant therapy for breast cancer].
    Shimizu C; Watanabe T
    Gan To Kagaku Ryoho; 2002 Dec; 29(13):2458-69. PubMed ID: 12506467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aromatase inhibitors for the endocrine adjuvant treatment of breast cancer.
    Ravdin P
    Lancet; 2002 Jun; 359(9324):2126-7. PubMed ID: 12090973
    [No Abstract]   [Full Text] [Related]  

  • 13. Scottish adjuvant breast cancer trials: results in pre-menopausal patients.
    Stewart HJ
    Recent Results Cancer Res; 1989; 115():126-31. PubMed ID: 2696025
    [No Abstract]   [Full Text] [Related]  

  • 14. Response to "benefit of radiation boost after whole-breast radiotherapy" (Int J Radiat Oncol Biol Phys 2009;75:1029-1034).
    Voogd AC; van der Sangen MJ
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):316; author reply 316. PubMed ID: 20394861
    [No Abstract]   [Full Text] [Related]  

  • 15. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials.
    Taghian A; Jeong JH; Mamounas E; Anderson S; Bryant J; Deutsch M; Wolmark N
    J Clin Oncol; 2004 Nov; 22(21):4247-54. PubMed ID: 15452182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor stem cells and the curability of early human breast cancer.
    Jasmin C
    Recent Results Cancer Res; 1993; 127():7-12. PubMed ID: 8502832
    [No Abstract]   [Full Text] [Related]  

  • 17. Increasing Precision in Adjuvant Therapy for Breast Cancer.
    Hudis CA; Dickler M
    N Engl J Med; 2016 Aug; 375(8):790-1. PubMed ID: 27557306
    [No Abstract]   [Full Text] [Related]  

  • 18. Adjuvant systemic therapy for early breast cancer: progress and controversies.
    Hortobagyi GN
    Clin Cancer Res; 2001 Jul; 7(7):1839-42. PubMed ID: 11448893
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant therapy in breast cancer.
    Robert NJ
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):693-707. PubMed ID: 7731642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial.
    Kunkler I
    J Natl Cancer Inst; 2005 Aug; 97(15):1162-3; author reply 1163-4. PubMed ID: 16077078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.